Articles tagged with: Enbrel
Headline, News »
Myelodysplastic syndromes (MDS) patients show higher and prolonged response rates to Vidaza (azacitidine) in combination with Enbrel (etanercept) than to Vidaza alone, according to a Phase 2 study recently published in the British Journal of Haemotology.
However, the study authors point out that the improved responses were improved marrow responses rather than improvements in blood cell development.
Vidaza, approved by the US Food and Drug Administration in 2004, is a widely used therapy for MDS. However, many MDS patients either do not respond or only have limited or brief responses, leading researchers…